The pharmaceutical industry's relentless pursuit of novel and effective treatments is underpinned by a robust supply chain of high-quality chemical intermediates. Among these, 4-Chlorobutyl 3,4-dimethoxybenzoate, identified by CAS number 69788-75-6, holds significant importance, primarily as an intermediate in the synthesis of Mebeverine. Navigating the market for such specialized compounds requires a keen understanding of chemical properties, supplier capabilities, and market dynamics.

4-Chlorobutyl 3,4-dimethoxybenzoate is a light yellow oily liquid with a molecular formula of C13H17ClO4 and a molecular weight of 272.72500. Its specifications, including an assay of ≥98.0%, ensure its suitability for demanding pharmaceutical applications where purity is non-negotiable. The compound's role as a precursor to Mebeverine highlights its value in producing gastrointestinal therapeutics. For pharmaceutical companies, ensuring a steady supply of this intermediate is critical for uninterrupted production cycles.

When evaluating suppliers, several factors come into play. Reliability, demonstrated through consistent product quality and timely delivery, is paramount. Manufacturers with established quality management systems, such as those adhering to ISO standards or good manufacturing practices (GMP), are highly preferred. Furthermore, the ability to provide substantial bulk quantities is essential for commercial-scale production. Sourcing from China has become a strategic advantage for many global pharmaceutical firms, offering access to a vast chemical manufacturing infrastructure and competitive pricing.

As a leading pharmaceutical intermediate supplier, NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to meeting these demands. We provide 4-Chlorobutyl 3,4-dimethoxybenzoate with a commitment to purity and scalability. Understanding the market prospects, which are tied to the global growth of the pharmaceutical sector, we continuously strive to optimize our production and supply chain. Companies looking to purchase this intermediate are encouraged to inquire about our bulk supply options and competitive pricing to ensure a stable and cost-effective procurement process.

In conclusion, securing 4-Chlorobutyl 3,4-dimethoxybenzoate from a trusted manufacturer is a strategic decision for pharmaceutical companies. By prioritizing quality, reliability, and competitive pricing, businesses can ensure the seamless production of essential medications like Mebeverine.